Abstract
Over the past few centuries, life-saving tools have been extensively used across the globe. The use of medical devices has increased adverse events associated with them. Materiovigilance is the process of identifying, collecting, reporting, and examining unfavorable events connected to medical devices in order to prevent the recurrence of such occurrences. Several countries keep an eye on medical products once they are commercialized. Other nations with similar programs include France, Australia, and the United Kingdom, in addition to the Medical Device Reporting (MDR) programme in the United States. This article addressed how some types of medical equipment might be dangerous and how a Materiovigilance programme is essential.
This page provides information about how to report adverse reactions to these medical devices, as well as what they are.
In many countries, post-marketing surveillance for medications has been initiated but is not as reliable and advanced as it is today. By monitoring adverse events related to medical devices, generating safety data, educating stakeholders, and recommending appropriate procedures and interventions, the Indian Pharmacopeia Commission established the committee on July 6, 2015.
Monitoring adverse events related to medical device usage can increase patient safety. On the basis of safety data gathered and generated, the Central Drugs Standard Control Organization (CDSCO) will make recommendations about the safe use of medical devices in the Indian population.
Related Books
Biopolymers Towards Green and Sustainable Development
Free Radical Biology of Endocrine, Metabolic & Immune Disorders
Advances in Combustion Synthesis and Technology
Applications of Modern Mass Spectrometry
Graphene-Based Nanomaterial Catalysis
Applications of NMR Spectroscopy
Surface Enhanced Raman Spectroscopy: Biosensing and Diagnostic Technique for Healthcare Applications
Biochemical Mechanisms of Aluminium Induced Neurological Disorders
Biochemistry: Fundamentals and Bioenergetics
Mind Maps in Clinical Chemistry (Part II)
